This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the 1990s, Michel Sadelain then at Memorial Sloan Kettering Cancer Center (MSKCC) designed CARs by combining fragments of tumor-recognizing antibodies with the molecular machinery found in T-cell receptors. That ability to stick around, which is critical for attacking cancer over time, was another turning point.
Also, last week’s digest had an error: The country that approved the malaria vaccine was Ghana. 🔥 Five Amazing Things (That happened this week…) 1/ CRISPR Protein Penetrates Cells Not one, but two new papers report a better way to deliver Cas9 or Cas12 gene-editing proteins into living cells. Things are good.
Also, last week’s digest had an error: The country that approved the malaria vaccine was Ghana. 🔥 Five Amazing Things (That happened this week…) 1/ CRISPR Protein Penetrates Cells Not one, but two new papers report a better way to deliver Cas9 or Cas12 gene-editing proteins into living cells. Things are good.
Read Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. Read Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine. npj Vaccines. Nature CellBiology. Video explaining mRNA vaccines (h/t Morgan Cheatham ).
This looks like an early step toward a much different future for biology: One in which natural language is used to design experiments, program robots, and automate experiments in high-throughput. Skin microbes can trigger strong immuneresponses. epidermidis , can actually trigger tumor-specific T cells. Cell Reports.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content